A prospective, pilot study on the use of olanzapine for optimum control of chemotherapy induced nausea and vomiting (CINV) in children with solid tumours receiving moderate/highly emetogenic chemotherapy at Tata Medical Center, Kolkata

• Samik Samaddar,
• Sonal Dalvi Mitra,
• Prakriti Roy,
• Vaskar Saha,
• Shekhar Krishnan,
• Anirban Das,
• Arpita Bhattacharyya

Affiliations

Samik Samaddar

Paediatric Haematology/Oncology, Tata Medical Centre, Kolkata, India

Sonal Dalvi Mitra

Paediatric Haematology/Oncology, Tata Medical Centre, Kolkata, India

Prakriti Roy

Tata Translational Cancer Research Centre, Tata Medical Centre, Kolkata, India

Vaskar Saha

Paediatric Haematology/Oncology, Tata Medical Centre, Kolkata, India

Shekhar Krishnan

Paediatric Haematology/Oncology, Tata Medical Centre, Kolkata, India

Anirban Das

Paediatric Haematology/Oncology, Tata Medical Centre, Kolkata, India

Arpita Bhattacharyya

Paediatric Haematology/Oncology, Tata Medical Centre, Kolkata, India